1. 1094PClinical prognostic factors in patients (pts) with recurrent and/or metastatic (RM) head and neck carcinoma (HNC) treated with cetuximab plus chemotherapy. (23rd October 2018) Authors: Bossi, P; Depenni, R; cossu rocca, M; Ferrari, D; Azzarello, G; Alù, M; Nolè, F; Codecà, C; Boscolo, G; Piccininni, M; Cavalieri, S; Pugliese, G; Licitra, L F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1472PImmunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience. (23rd October 2018) Authors: Luciani, A; Toschi, L; Fava, S; Cortinovis, D; Filipazzi, V; Tuzi, A; Marra, A; Rossi, S; Rossi, A; Blasi, M; Violati, M; Sala, L; Agustoni, F; Bidoli, P; Zonato, S; Ferrari, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 27 Therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer. (13th November 2020) Authors: Bizzarri, N; Du Bois, A; Fruscio, R; De Felice, F; De Iaco, P; Casarin, J; Vizza, E; Chiantera, V; Corrado, G; Cianci, S; Harter, P; Ataseven, B; Bommert, M; Perrone, AM; Magni, S; Ferrari, D; Zambetti, B; Scambia, G; Fagotti, A Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 522PPrognostic value of neutrophil-lymphocite ratio in resected high risk colorectal cancer: An analysis of adjuvant TOSCA trial. (23rd October 2018) Authors: Petrelli, F; Rosati, G; Banzi, M; Zampino, M G; Pella, N; Di Bartolomeo, M; Maiello, E; Bidoli, P; Ferrari, D; Rimassa, L; Labianca, R; Scartozzi, M; Lonardi, S; de Placido, S; Zaniboni, A; Sobrero, A; Frassineti, L G; Silvestris, N; Corsi, D; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 583PThromboembolic risk and survival with Khorana score in resected colorectal cancer patients: Subgroup analysis from the adjuvant TOSCA trial. (23rd October 2018) Authors: Barni, S; Rosati, G; Zagonel, V; Pella, N; Banzi, M; Zampino, M G; Di Bartolomeo, M; Rimassa, L; Marchetti, P; Maiello, E; Artioli, F; Ferrari, D; Labianca, R; Bidoli, P; Zaniboni, A; Sobrero, A; Iaffaioli, V; de Placido, S; Frassineti, L G; Galli, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial. (1st October 2019) Authors: Cascinu, S; Berardi, R; Bianco, R; Bilancia, D; Zaniboni, A; Ferrari, D; Mosconi, S; Spallanzani, A; Cavanna, L; Leo, S; Negri, F; Beretta, G D; Sobrero, A; Banzi, M; Morabito, A; Bittoni, A; Marciano, R; Ferrara, D; Noventa, S; Piccirillo, M C Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Contrast-enhanced ultrasound in the evaluation of parotid gland lesions: an update of the literature. (May 2016) Authors: David, E; Cantisani, V; De Vincentiis, M; Sidhu, PS; Greco, A; Tombolini, M; Drudi, FM; Messineo, D; Gigli, S; Rubini, A; Fresilli, D; Ferrari, D; Flammia, F; D'Ambrosio, F Journal: Ultrasound Issue: Volume 24:Number 2(2016:May) Page Start: 104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-291The DISTINCTIVE study: A biologically enriched phase II study of seconD-line folfiri/aflIbercept in proSpecTIvely stratified, anti-EGFR resistaNt, metastatic coloreCTal cancer patIents with RAS Validated wild typE status - Trial in progress. (20th June 2018) Authors: Ziranu, P; Demurtas, L; Puzzoni, M; Loupakis, F; Daniele, B; Rimassa, L; Bilancia, D; Lonardi, S; Avallone, A; Pella, N; Ferrari, D; Frassineti, L; Beretta, G; Zaniboni, A; Santoro, A; Zampino, M; Sarobba, M; Zagonel, V; Barni, S; Palmieri, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reduction of spillover effects on independent modal space control through optimal placement of sensors and actuators. (2nd July 2015) Authors: Cinquemani, S; Ferrari, D; Bayati, I Journal: Smart materials and structures Issue: Volume 24:Number 8(2015:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗